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Correction
Error in Table 3. In the article titled “Meta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons” by
Woolcott et al, published in the November 23, 2009, issue of the Archives (2009;169[21]:1952-1960), the second half of
Table 3 was inadvertently omitted. The complete table should have read as follows:
Table 3. Pooled Bayesian Odds Ratios and Subgroup Sensitivity Analysis
Study Characteristic
Antihypertensives Diuretics -Blockers Sedatives/Hypnotics
No.a OR (95% CI) No.a OR (95% CI) No.a OR (95% CI) No.a OR (95% CI)
No. of subjects 4976 10 145 8354 44 684
No. taking drug 1482 2374 1432 1737
All studies 6 1.24 (1.01-1.50) 9 1.07 (1.01-1.14) 4 1.01 (0.86-1.17) 7 1.47 (1.35-1.62)
Population
Community 4 1.29 (1.00-1.65) 3 1.08 (1.01-1.16) 2 0.98 (0.79-1.18)b 5 1.50 (1.36-1.67)
35% Fallers 3 1.34 (0.93-1.91) 2 1.09 (1.00-1.17) 1 0.94 (0.75-1.16) 3 1.62 (1.44-1.84)b
35% Fallers 1 1.11 (0.78-1.58)c 1 1.04 (0.87-1.24) 1 1.13 (0.72-1.70) 2 1.22 (1.00-1.48)b
Long-term care 1 0.80 (0.40-1.60)c 3 1.02 (0.84-1.25) 2 1.18 (0.83-1.88)b 1 1.38 (1.14-1.74)
Other 1 1.19 (0.77-1.83)c 3 1.06 (0.82-1.38) 0 0.43 (0.19-0.97)b 1 1.56 (1.19-2.05)
Mean age of study subjects, y
75 4 1.33 (1.03-1.68) 4 1.11 (1.03-1.20)b 2 0.93 (0.71-1.18) 4 1.54 (1.39-1.72)
75 2 1.04 (0.79-1.38)c 5 0.96 (0.84-1.08)b 2 1.02 (0.81-1.28) 3 1.37 (1.19-1.60)
Medication/falls ascertainment
Good 1 1.19 (0.77-1.83)c 5 1.04 (0.89-1.23) 1 0.87 (0.69-1.07) 1 1.66 (1.25-2.22)
Poor 5 1.24 (0.97-1.54) 4 1.09 (1.02-1.16) 3 1.02 (0.84-1.21) 6 1.43 (1.30-1.58)
Study type
Case-control 2 1.09 (0.80-1.50)c 5 1.11 (0.94-1.32) 1 0.87 (0.55-1.37) 1 1.62 (1.31-2.00)b
Cohort 3 1.34 (0.93-1.91) 1 1.05 (0.97-1.15) 0 1.00 (0.78-1.30) 3 1.24 (1.05-1.45)b
Cross-sectional 1 1.11 (0.78-1.58)c 3 1.11 (1.00-1.24) 3 1.02 (0.79-1.24) 3 1.56 (1.39-1.76)b
Neuroleptics/
Antipsychotics Antidepressants Benzodiazepines Narcotics NSAIDs
Study Characteristic No.a OR (95% CI) No.a OR (95% CI) No.a OR (95% CI) No.a OR (95% CI) No.a OR (95% CI)
No. of subjects 8617 20 469 32 684 12 811 7828
No. taking drug 1303 3021 5050 1314 429
All studies 4 1.59 (1.37-1.83) 9 1.68 (1.47-1.91) 11 1.57 (1.43-1.72) 4 0.96 (0.78-1.18) 4 1.21 (1.01-1.44)
Population
Community 2 1.76 (1.41-2.18)b 4 1.68 (1.39-2.03) 6 1.55 (1.36-1.73) 2 1.22 (0.79-1.66) 1 1.12 (0.91-1.36)
35% Fallers 1 1.75 (1.36-2.24) 3 1.62 (1.22-2.03) 5 1.53 (1.31-1.75) 2 1.32 (0.87-1.80) 1 1.08 (0.86-1.34)
35% Fallers 1 1.78 (1.33-2.38)c 1 2.30 (1.41-3.69) 1 1.58 (1.05-2.45) 0 0.71 (0.27-1.82) 0 1.34 (0.83-2.15)
Long-term care 1 1.55 (1.24-1.95) 3 1.63 (1.35-1.98) 2 1.43 (1.11-1.85) 1 1.03 (0.61-1.54) 1 1.41 (1.05-1.89)
Other 1 1.02 (0.65-1.61)b 2 1.70 (1.17-2.48) 3 1.91 (1.43-2.55) 1 0.94 (0.72-1.24) 2 1.62 (0.21-12.60)c
Mean age of study subjects, y
75 1 1.72 (1.32-2.27) 2 1.66 (1.33-2.04) 5 1.55 (1.26-1.83) 1 0.96 (0.73-1.27) 2 1.26 (0.92-1.70)
75 3 1.63 (1.27-2.03) 7 1.79 (1.47-2.16) 6 1.56 (1.39-1.77) 3 1.24 (0.75-1.65) 2 1.17 (0.95-1.43)
Medication/falls ascertainment
Good 2 1.34 (1.05-1.68)b 4 1.68 (1.39-2.06) 5 1.65 (1.39-1.98) 2 0.81 (0.55-1.20) 3 1.59 (1.11-2.24)b
Poor 2 1.79 (1.46-2.17)b 5 1.64 (1.37-1.94) 6 1.54 (1.36-1.72) 2 1.11 (0.85-1.42) 1 1.12 (0.93-1.35)b
Study type
Case-control 1 1.23 (0.92-1.63) 3 1.83 (1.42-2.35) 3 2.18 (1.57-3.12)b 1 0.21 (0.10-0.45)b,c 2 1.62 (0.21-12.60)c
Cohort 0 1.90 (1.35-2.67) 2 1.67 (1.36-2.02) 3 1.51 (1.29-1.75)b 1 1.49 (1.22-1.83)b,c 0 NA
Cross-sectional 3 1.67 (1.38-2.00) 4 1.57 (1.25-1.96) 5 1.49 (1.24-1.73)b 2 1.18 (0.90-1.53)b,c 2 1.44 (0.49-4.03)c
Abbreviations: CI, confidence interval; NA, not applicable; NSAIDs, nonsteroidal anti-inflammatory drugs; OR, odds ratio.
aRefers to new study only.
bGreater than 95% posterior probability that the difference between ORs is greater than 0.
cAttained by random-effects inverse-variance model (frequentist) owing to unstable Bayesian model.
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